loader
Please Wait
Applying Filters...

Annual Sales of MolPort-001-641-065 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 47Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Lasix

02 1Salix

PharmaCompass

01

Brand Name : Lasix

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Furosemide

Main Therapeutic Indication : Cardiovascular

Currency : USD

2014 Revenue in Millions : -4.70%

2013 Revenue in Millions :

Growth (%) :

Sanofi Company Banner

02

Brand Name : Lasix

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Furosemide

Main Therapeutic Indication : Cardiovascular

Currency : USD

2015 Revenue in Millions : 180

2014 Revenue in Millions : 178

Growth (%) : -1%

Sanofi Company Banner

03

Brand Name : Lasix

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Furosemide

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 157

2015 Revenue in Millions : 172

Growth (%) : -9

Sanofi Company Banner

04

Brand Name : Lasix

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Furosemide

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 170

2016 Revenue in Millions : 184

Growth (%) : -7

Sanofi Company Banner

05

Brand Name : Lasix

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Furosemide

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 0

2017 Revenue in Millions : 155

Growth (%) : -100%

Sanofi Company Banner

06

Brand Name : Salix

arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Salix

arrow
Boulder Peptide 2024
Not Confirmed

Main Therapeutic Indication :

Currency : USD

2018 Revenue in Millions : 1,749

2017 Revenue in Millions : 1,566

Growth (%) : 12%

blank